版本:
中国

BRIEF-Myriad Genetics announced new data "demonstrating utility" of prolaris test

May 12 Myriad Genetics Inc:

* Myriad Genetics - announced new data "demonstrating utility" of prolaris test to predict 10-year risk of metastases in men treated for prostate cancer Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐